Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaSeptember 6, 2022
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaAugust 1, 2022
MaaT Pharma Reports Cash and Revenues for Second Quarter 2022 As of June 30, 2022,…
MaaT PharmaJuly 28, 2022
MaaT Pharma Announces the Availability of the 2021 Universal Registration Document Lyon, France, July 6,…
MaaT PharmaJuly 6, 2022
MaaT Pharma Confirms Positive Results from Completed Phase 1b CIMON Study Evaluating MaaT033 in Blood…
MaaT PharmaJune 2, 2022
MaaT Pharma Announces Combined General Meeting on May 31, 2022 and the Availability of the…
MaaT PharmaMay 10, 2022
MaaT Pharma Announces Resignation of an Independent Board Member Lyon, France, May 10th, 2022 –…
MaaT PharmaMay 10, 2022
MaaT Pharma Reports Cash and Revenues for first quarter 2022 As of March 31, 2022,…
MaaT PharmaMay 5, 2022
